Mirum Pharmaceuticals (MIRM) Return on Sales (2021 - 2026)

Mirum Pharmaceuticals' Return on Sales history runs 6 years deep, the most recent figure standing at 0.05% for Q1 2026.

• In Q1 2026, Return on Sales fell 5.0% year-over-year to 0.05%; the TTM figure through Mar 2026 stood at 0.01% (down 1.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
• Return on Sales was 0.05% for Q1 2026 at Mirum Pharmaceuticals, down from 0.0% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.0% in Q3 2025 to a low of 0.05% in Q1 2026.
• Historically, Return on Sales has averaged 0.01% across 5 years, with a median of 0.0% in 2023.
• Biggest YoY gain for Return on Sales was 8 bps in 2022; the steepest drop was 20 bps in 2022.
• A 5-year view of Return on Sales shows it stood at 0.01% in 2022, then soared by 61 bps to 0.01% in 2023, then soared by 53 bps to 0.0% in 2024, then jumped by 84 bps to 0.0% in 2025, then plunged by 12745 bps to 0.05% in 2026.
• The last three Return on Sales figures came in at 0.05% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.